Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

Table 3 Evolution of functional performance between M0 and M6

	M0	M6	M6-M0	p
	(N = 1490)	(N = 1354)	M6-M0	p
GAF rating score^a	46.4 ± 0.54	52.2 ± 0.67	5.8 ± 0.45	< 0.001
Social functioning rating score^b	18.3 ± 0.11	20.2 ± 0.12	1.9 ± 0.10	< 0.001
Social skills	11.4 ± 0.06	12.5 ± 0.07	1.1 ± 0.07	< 0.001
Social roles	6.90 ± 0.05	7.73 ± 0.06	0.83 ± 0.05	< 0.001

Values are given as mean ± SEM. M0, month 0 (inclusion). M6, month 6 (end of study)
^aMaximum GAF rating score = 100
^bSocial functioning rating scores = total (from 7 to 28), social skills (from 4 to 6) and social roles (from 3 to 12)

ISSN: 1471-244X